Roche Diabetes Care and ICW Announce Technology Partnership

InterComponentWare (ICW)Roche Diabetes Care, a global leader in diabetes care and eHealth specialist InterComponentWare (ICW) announced a multi-year, global partnership to develop a next-generation web-based solution for efficient diabetes management.

The structured evaluation and communication of blood glucose monitoring and insulin data is a pivotal part in efficient diabetes management. Until today, this poses a significant challenge for both people with diabetes and healthcare professionals. Developing a solution to ease the interaction between patients and healthcare providers will be the goal of the technology partnership Roche Diabetes Care and ICW have announced today.

Using the very successful Accu-Chek® 360° software and the powerful ICW eHealth Framework (eHF) as well as other solution components, Roche Diabetes Care and ICW will jointly develop a technology platform that will facilitate the secure sharing of data and communications between healthcare professionals and people with diabetes via the web and allow patients and caregivers to manage diabetes even more efficiently. Already today, the Accu-Chek 360° software allows for well-structured visualization and assessment of important blood glucose and insulin data and enables healthcare professionals, as well as people with diabetes, to determine appropriate therapy.

Burkhard G. Piper, President Roche Diabetes Care, notes, "We conducted a comprehensive search for a technology partner and we were pleased to select ICW. It is our goal to continuously improve the information exchange between patients and their caregivers. We aim to provide new solutions that can facilitate the exchange of health data that are key for successful therapeutic interventions. Combining our knowledge and expertise, we will be able to leverage web-based technologies and make significant advances in the areas of connectivity between patients and healthcare professionals."

"The agreement with Roche Diabetes Care represents a culmination of our development efforts to date," explains Peter Kirschbauer, CEO of ICW AG. "Roche Diabetes Care will leverage the ICW eHealth Framework and our successful deployment of the highest security standards for information exchange, as we co-develop new and advanced approaches to sharing relevant diabetes data. We are very pleased to have Roche Diabetes Care as our partner."

Related news articles:

About ICW
InterComponentWare AG (ICW) is a leading international eHealth specialist with locations in Germany, Austria, Switzerland and the USA. ICW supplies interoperable eHealth infrastructure solutions and applications to the providers of healthcare services and their patients. ICW technologies make it possible for institutions to expand their existing IT infrastructure, to network with dissimilar systems, and to store patient data in a secure environment. ICW solutions make aggregated data a reality. ICW has installed its solutions successfully in Europe and North America. For more information, go to www.icw-global.com.

Most Popular Now

Most Advanced Artificial Touch for Brain…

For the first time ever, a complex sense of touch for individuals living with spinal cord injuries is a step closer to reality. A new study published in Science, paves...

Predicting the Progression of Autoimmune…

Autoimmune diseases, where the immune system mistakenly attacks the body's own healthy cells and tissues, often have a preclinical stage before diagnosis that’s characterized by mild symptoms or certain antibodies...

Major EU Project to Investigate Societal…

A new €3 million EU research project led by University College Dublin (UCD) Centre for Digital Policy will explore the benefits and risks of Artificial Intelligence (AI) from a societal...

Using AI to Uncover Hospital Patients�…

Across the United States, no hospital is the same. Equipment, staffing, technical capabilities, and patient populations can all differ. So, while the profiles developed for people with common conditions may...

New AI Tool Uses Routine Blood Tests to …

Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will benefit from immune checkpoint inhibitors - a type of...

New Method Tracks the 'Learning Cur…

Introducing Annotatability - a powerful new framework to address a major challenge in biological research by examining how artificial neural networks learn to label genomic data. Genomic datasets often contain...

Picking the Right Doctor? AI could Help

Years ago, as she sat in waiting rooms, Maytal Saar-Tsechansky began to wonder how people chose a good doctor when they had no way of knowing a doctor's track record...

From Text to Structured Information Secu…

Artificial intelligence (AI) and above all large language models (LLMs), which also form the basis for ChatGPT, are increasingly in demand in hospitals. However, patient data must always be protected...

AI Innovation Unlocks Non-Surgical Way t…

Researchers have developed an artificial intelligence (AI) model to detect the spread of metastatic brain cancer using MRI scans, offering insights into patients’ cancer without aggressive surgery. The proof-of-concept study, co-led...

Deep Learning Model Helps Detect Lung Tu…

A new deep learning model shows promise in detecting and segmenting lung tumors, according to a study published in Radiology, a journal of the Radiological Society of North America (RSNA)...

New Study Reveals AI's Transformati…

Intensive care units (ICUs) face mounting pressure to effectively manage resources while delivering optimal patient care. Groundbreaking research published in the INFORMS journal Information Systems Research highlights how a novel...

One of the Largest Global Surveys of Soc…

As leaders gather for the World Economic Forum Annual Meeting 2025 in Davos, Leaps by Bayer, the impact investing arm of Bayer, and Boston Consulting Group (BCG) announced the launch...